{
    "clinical_study": {
        "@rank": "38417", 
        "arm_group": [
            {
                "arm_group_label": "Dapsone Formulation A", 
                "arm_group_type": "Experimental", 
                "description": "Dapsone Formulation A applied once daily to the face, upper chest, upper back, and shoulders for 28 days."
            }, 
            {
                "arm_group_label": "Dapsone Formulation B", 
                "arm_group_type": "Experimental", 
                "description": "Dapsone Formulation B applied once daily to the face, upper chest, upper back, and shoulders for 28 days."
            }, 
            {
                "arm_group_label": "Dapsone Formulation C", 
                "arm_group_type": "Experimental", 
                "description": "Dapsone Formulation C applied once daily to the face, upper chest, upper back, and shoulders for 28 days."
            }, 
            {
                "arm_group_label": "Dapsone 5% Gel", 
                "arm_group_type": "Active Comparator", 
                "description": "Dapsone 5% gel (ACZONE\u00ae) applied twice daily to the face, upper chest, upper back, and shoulders for 28 days."
            }
        ], 
        "brief_summary": {
            "textblock": "This study will evaluate the safety, tolerability, and pharmacokinetics (PK) of dapsone in\n      subjects with acne vulgaris following 28 days of dosing."
        }, 
        "brief_title": "Safety, Tolerability, and Pharmacokinetics of Dapsone in Acne Vulgaris", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "B1", 
                            "description": "Dapsone Formulation A applied once daily to the face, upper chest, upper back, and shoulders for 28 days.", 
                            "title": "Dapsone Formulation A"
                        }, 
                        {
                            "@group_id": "B2", 
                            "description": "Dapsone Formulation B applied once daily to the face, upper chest, upper back, and shoulders for 28 days.", 
                            "title": "Dapsone Formulation B"
                        }, 
                        {
                            "@group_id": "B3", 
                            "description": "Dapsone Formulation C applied once daily to the face, upper chest, upper back, and shoulders for 28 days.", 
                            "title": "Dapsone Formulation C"
                        }, 
                        {
                            "@group_id": "B4", 
                            "description": "Dapsone 5% gel (ACZONE\u00ae) applied twice daily to the face, upper chest, upper back, and shoulders for 28 days.", 
                            "title": "Dapsone 5% Gel"
                        }, 
                        {
                            "@group_id": "B5", 
                            "description": "Total of all reporting groups", 
                            "title": "Total"
                        }
                    ]
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@value": "20"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@value": "19"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@value": "19"
                                            }, 
                                            {
                                                "@group_id": "B4", 
                                                "@value": "19"
                                            }, 
                                            {
                                                "@group_id": "B5", 
                                                "@value": "77"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "8"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "7"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "7"
                                                }, 
                                                {
                                                    "@group_id": "B4", 
                                                    "@value": "7"
                                                }, 
                                                {
                                                    "@group_id": "B5", 
                                                    "@value": "29"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "12 to 17 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "12"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "12"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "12"
                                                }, 
                                                {
                                                    "@group_id": "B4", 
                                                    "@value": "12"
                                                }, 
                                                {
                                                    "@group_id": "B5", 
                                                    "@value": "48"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "18 to 35 years"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Age, Customized", 
                            "units": "Participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "8"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "9"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "10"
                                                }, 
                                                {
                                                    "@group_id": "B4", 
                                                    "@value": "9"
                                                }, 
                                                {
                                                    "@group_id": "B5", 
                                                    "@value": "36"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "12"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "10"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "9"
                                                }, 
                                                {
                                                    "@group_id": "B4", 
                                                    "@value": "10"
                                                }, 
                                                {
                                                    "@group_id": "B5", 
                                                    "@value": "41"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "Participants"
                        }
                    ]
                }
            }, 
            "certain_agreements": {
                "pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.", 
                "restrictive_agreement": "A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo."
            }, 
            "outcome_list": {
                "outcome": [
                    {
                        "description": "Cmax is the maximum plasma level following multiple doses of dapsone. Plasma is the liquid component of the blood in which the blood cells are suspended.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Dapsone Formulation A applied once daily to the face, upper chest, upper back, and shoulders for 28 days.", 
                                    "title": "Dapsone Formulation A"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Dapsone Formulation B applied once daily to the face, upper chest, upper back, and shoulders for 28 days.", 
                                    "title": "Dapsone Formulation B"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "Dapsone Formulation C applied once daily to the face, upper chest, upper back, and shoulders for 28 days.", 
                                    "title": "Dapsone Formulation C"
                                }, 
                                {
                                    "@group_id": "O4", 
                                    "description": "Dapsone 5% gel (ACZONE\u00ae) applied twice daily to the face, upper chest, upper back, and shoulders for 28 days.", 
                                    "title": "Dapsone 5% Gel"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "17"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "18"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "19"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@value": "18"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "5.5", 
                                                        "@value": "11.7"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "8.8", 
                                                        "@value": "14.1"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@spread": "6.8", 
                                                        "@value": "13.0"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@spread": "6.7", 
                                                        "@value": "17.6"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Cmax is the maximum plasma level following multiple doses of dapsone. Plasma is the liquid component of the blood in which the blood cells are suspended.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Maximum Plasma Level (Cmax) of Dapsone", 
                                    "units": "Nanograms/Milliliter (ng/mL)"
                                }
                            ]
                        }, 
                        "population": "All treated subjects with data for this time point", 
                        "safety_issue": "No", 
                        "time_frame": "Day 28", 
                        "title": "Maximum Plasma Level (Cmax) of Dapsone", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Cmax is the maximum plasma level following multiple doses of dapsone. Plasma is the liquid component of the blood in which the blood cells are suspended. The dapsone metabolites are N-acetyl dapsone and dapsone hydroxylamine.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Dapsone Formulation A applied once daily to the face, upper chest, upper back, and shoulders for 28 days.", 
                                    "title": "Dapsone Formulation A"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Dapsone Formulation B applied once daily to the face, upper chest, upper back, and shoulders for 28 days.", 
                                    "title": "Dapsone Formulation B"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "Dapsone Formulation C applied once daily to the face, upper chest, upper back, and shoulders for 28 days.", 
                                    "title": "Dapsone Formulation C"
                                }, 
                                {
                                    "@group_id": "O4", 
                                    "description": "Dapsone 5% gel (ACZONE\u00ae) applied twice daily to the face, upper chest, upper back, and shoulders for 28 days.", 
                                    "title": "Dapsone 5% Gel"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "17"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "18"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "19"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@value": "18"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "4.25", 
                                                            "@value": "5.44"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "3.85", 
                                                            "@value": "6.00"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@spread": "5.43", 
                                                            "@value": "6.47"
                                                        }, 
                                                        {
                                                            "@group_id": "O4", 
                                                            "@spread": "8.8", 
                                                            "@value": "11.7"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "N-Acetyl Dapsone"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "0.433", 
                                                            "@value": "0.908"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "0.46", 
                                                            "@value": "1.11"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@spread": "0.76", 
                                                            "@value": "1.19"
                                                        }, 
                                                        {
                                                            "@group_id": "O4", 
                                                            "@spread": "0.56", 
                                                            "@value": "1.47"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Dapsone Hydroxylamine"
                                            }
                                        ]
                                    }, 
                                    "description": "Cmax is the maximum plasma level following multiple doses of dapsone. Plasma is the liquid component of the blood in which the blood cells are suspended. The dapsone metabolites are N-acetyl dapsone and dapsone hydroxylamine.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Maximum Plasma Level (Cmax) of Dapsone Metabolites", 
                                    "units": "Nanograms/Milliliter (ng/mL)"
                                }
                            ]
                        }, 
                        "population": "All treated subjects with data for this time point", 
                        "safety_issue": "No", 
                        "time_frame": "Day 28", 
                        "title": "Maximum Plasma Level (Cmax) of Dapsone Metabolites", 
                        "type": "Secondary"
                    }
                ]
            }, 
            "participant_flow": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "P1", 
                            "description": "Dapsone Formulation A applied once daily to the face, upper chest, upper back, and shoulders for 28 days.", 
                            "title": "Dapsone Formulation A"
                        }, 
                        {
                            "@group_id": "P2", 
                            "description": "Dapsone Formulation B applied once daily to the face, upper chest, upper back, and shoulders for 28 days.", 
                            "title": "Dapsone Formulation B"
                        }, 
                        {
                            "@group_id": "P3", 
                            "description": "Dapsone Formulation C applied once daily to the face, upper chest, upper back, and shoulders for 28 days.", 
                            "title": "Dapsone Formulation C"
                        }, 
                        {
                            "@group_id": "P4", 
                            "description": "Dapsone 5% gel (ACZONE\u00ae) applied twice daily to the face, upper chest, upper back, and shoulders for 28 days.", 
                            "title": "Dapsone 5% Gel"
                        }
                    ]
                }, 
                "period_list": {
                    "period": {
                        "drop_withdraw_reason_list": {
                            "drop_withdraw_reason": {
                                "participants_list": {
                                    "participants": [
                                        {
                                            "@count": "3", 
                                            "@group_id": "P1"
                                        }, 
                                        {
                                            "@count": "1", 
                                            "@group_id": "P2"
                                        }, 
                                        {
                                            "@count": "0", 
                                            "@group_id": "P3"
                                        }, 
                                        {
                                            "@count": "1", 
                                            "@group_id": "P4"
                                        }
                                    ]
                                }, 
                                "title": "Due to amended age eligibility criteria"
                            }
                        }, 
                        "milestone_list": {
                            "milestone": [
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "20", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "19", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "19", 
                                                "@group_id": "P3"
                                            }, 
                                            {
                                                "@count": "19", 
                                                "@group_id": "P4"
                                            }
                                        ]
                                    }, 
                                    "title": "STARTED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "17", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "18", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "19", 
                                                "@group_id": "P3"
                                            }, 
                                            {
                                                "@count": "18", 
                                                "@group_id": "P4"
                                            }
                                        ]
                                    }, 
                                    "title": "COMPLETED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "3", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "1", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P3"
                                            }, 
                                            {
                                                "@count": "1", 
                                                "@group_id": "P4"
                                            }
                                        ]
                                    }, 
                                    "title": "NOT COMPLETED"
                                }
                            ]
                        }, 
                        "title": "Overall Study"
                    }
                }, 
                "pre_assignment_details": "The protocol was amended mid-study to exclude patients <16 years."
            }, 
            "point_of_contact": {
                "email": "clinicaltrials@allergan.com", 
                "name_or_title": "Therapeutic  Area Head,", 
                "organization": "Allergan, Inc", 
                "phone": "714-246-4500"
            }, 
            "reported_events": {
                "desc": "The Safety Population consisted of all subjects who received at least 1 dose of study medication.  The Safety Population was used to assess adverse events (AEs) and serious adverse events (SAEs).", 
                "group_list": {
                    "group": [
                        {
                            "@group_id": "E1", 
                            "description": "Dapsone Formulation A applied once daily to the face, upper chest, upper back, and shoulders for 28 days.", 
                            "title": "Dapsone Formulation A"
                        }, 
                        {
                            "@group_id": "E2", 
                            "description": "Dapsone Formulation B applied once daily to the face, upper chest, upper back, and shoulders for 28 days.", 
                            "title": "Dapsone Formulation B"
                        }, 
                        {
                            "@group_id": "E3", 
                            "description": "Dapsone Formulation C applied once daily to the face, upper chest, upper back, and shoulders for 28 days.", 
                            "title": "Dapsone Formulation C"
                        }, 
                        {
                            "@group_id": "E4", 
                            "description": "Dapsone 5% gel (ACZONE\u00ae) applied twice daily to the face, upper chest, upper back, and shoulders for 28 days.", 
                            "title": "Dapsone 5% Gel"
                        }
                    ]
                }, 
                "other_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "20", 
                                                "@subjects_at_risk": "20"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "16", 
                                                "@subjects_at_risk": "19"
                                            }, 
                                            {
                                                "@group_id": "E3", 
                                                "@subjects_affected": "10", 
                                                "@subjects_at_risk": "19"
                                            }, 
                                            {
                                                "@group_id": "E4", 
                                                "@subjects_affected": "11", 
                                                "@subjects_at_risk": "19"
                                            }
                                        ], 
                                        "sub_title": "Total, other adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "assessment": "Non-systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "20"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E4", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }
                                            ], 
                                            "sub_title": "Diarrhoea"
                                        }, 
                                        {
                                            "assessment": "Non-systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "20"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E4", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }
                                            ], 
                                            "sub_title": "Nausea"
                                        }, 
                                        {
                                            "assessment": "Non-systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "20"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E4", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }
                                            ], 
                                            "sub_title": "Abdominal Pain Upper"
                                        }
                                    ]
                                }, 
                                "title": "Gastrointestinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "assessment": "Non-systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "20"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E4", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "19"
                                                }
                                            ], 
                                            "sub_title": "Pyrexia"
                                        }, 
                                        {
                                            "assessment": "Non-systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "20"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E4", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }
                                            ], 
                                            "sub_title": "Medical Device Pain"
                                        }, 
                                        {
                                            "assessment": "Non-systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "20"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E4", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }
                                            ], 
                                            "sub_title": "Non-Cardiac Chest Pain"
                                        }, 
                                        {
                                            "assessment": "Non-systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "20"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E4", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "19"
                                                }
                                            ], 
                                            "sub_title": "Influenza Like Illness"
                                        }
                                    ]
                                }, 
                                "title": "General disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "assessment": "Non-systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "20"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E4", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "19"
                                                }
                                            ], 
                                            "sub_title": "Pharyngitis"
                                        }, 
                                        {
                                            "assessment": "Non-systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "20"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E4", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "19"
                                                }
                                            ], 
                                            "sub_title": "Upper Respiratory Tract Infection"
                                        }, 
                                        {
                                            "assessment": "Non-systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "20"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E4", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }
                                            ], 
                                            "sub_title": "Sinusitis"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "20"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E4", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }
                                            ], 
                                            "sub_title": "Tinea Versicolour"
                                        }, 
                                        {
                                            "assessment": "Non-systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "20"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E4", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "19"
                                                }
                                            ], 
                                            "sub_title": "Influenza"
                                        }, 
                                        {
                                            "assessment": "Non-systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "20"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E4", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }
                                            ], 
                                            "sub_title": "Nasopharyngitis"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "20"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E4", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }
                                            ], 
                                            "sub_title": "Bronchitis"
                                        }
                                    ]
                                }, 
                                "title": "Infections and infestations"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "assessment": "Non-systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "20"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E4", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }
                                            ], 
                                            "sub_title": "Excoriation"
                                        }, 
                                        {
                                            "assessment": "Non-systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "20"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E4", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }
                                            ], 
                                            "sub_title": "Laceration"
                                        }, 
                                        {
                                            "assessment": "Non-systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "20"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E4", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }
                                            ], 
                                            "sub_title": "Sunburn"
                                        }
                                    ]
                                }, 
                                "title": "Injury, poisoning and procedural complications"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "assessment": "Non-systematic Assessment", 
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "20"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "19"
                                            }, 
                                            {
                                                "@group_id": "E3", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "19"
                                            }, 
                                            {
                                                "@group_id": "E4", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "19"
                                            }
                                        ], 
                                        "sub_title": "Pain in Extremity"
                                    }
                                }, 
                                "title": "Musculoskeletal and connective tissue disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "assessment": "Non-systematic Assessment", 
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "6", 
                                                "@subjects_at_risk": "20"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "19"
                                            }, 
                                            {
                                                "@group_id": "E3", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "19"
                                            }, 
                                            {
                                                "@group_id": "E4", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "19"
                                            }
                                        ], 
                                        "sub_title": "Headache"
                                    }
                                }, 
                                "title": "Nervous system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "assessment": "Non-systematic Assessment", 
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "8"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "9"
                                            }, 
                                            {
                                                "@group_id": "E3", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "10"
                                            }, 
                                            {
                                                "@group_id": "E4", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "9"
                                            }
                                        ], 
                                        "sub_title": "Dysmenorrhoea"
                                    }
                                }, 
                                "title": "Reproductive system and breast disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "assessment": "Non-systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "20"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E4", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "19"
                                                }
                                            ], 
                                            "sub_title": "Cough"
                                        }, 
                                        {
                                            "assessment": "Non-systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "20"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E4", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }
                                            ], 
                                            "sub_title": "Oropharyngeal Pain"
                                        }, 
                                        {
                                            "assessment": "Non-systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "20"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E4", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }
                                            ], 
                                            "sub_title": "Respiratory Tract Congestion"
                                        }, 
                                        {
                                            "assessment": "Non-systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "20"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E4", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "19"
                                                }
                                            ], 
                                            "sub_title": "Nasal Congestion"
                                        }
                                    ]
                                }, 
                                "title": "Respiratory, thoracic and mediastinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "assessment": "Non-systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "20"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E4", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }
                                            ], 
                                            "sub_title": "Eczema"
                                        }, 
                                        {
                                            "assessment": "Non-systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "20"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "19"
                                                }, 
                                                {
                                                    "@group_id": "E4", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "19"
                                                }
                                            ], 
                                            "sub_title": "Pruritus"
                                        }
                                    ]
                                }, 
                                "title": "Skin and subcutaneous tissue disorders"
                            }
                        ]
                    }, 
                    "default_assessment": "Systematic Assessment", 
                    "default_vocab": "MedDRA version 16.0", 
                    "frequency_threshold": "5"
                }
            }
        }, 
        "completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "condition": "Acne Vulgaris", 
        "condition_browse": {
            "mesh_term": "Acne Vulgaris"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis of acne vulgaris\n\n          -  Willing to avoid excessive or prolonged exposure to ultraviolet light (e.g.,\n             sunlight, tanning beds) throughout the study\n\n          -  If male, the subject must agree to shave the facial treatment area and agree to\n             maintain his routine shaving regimen for the duration of the study\n\n          -  willing to avoid applying moisturizers, sunscreens, cosmetics (except eye and lip\n             makeup), and chemical peels throughout the study\n\n        Exclusion Criteria:\n\n          -  Oral acne treatments within 6 months"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "35 Years", 
            "minimum_age": "16 Years"
        }, 
        "enrollment": {
            "#text": "77", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 18, 2013", 
        "firstreceived_results_date": "February 11, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01773122", 
            "org_study_id": "225678-004"
        }, 
        "intervention": [
            {
                "arm_group_label": "Dapsone Formulation A", 
                "description": "Dapsone Formulation A applied once daily to the face, upper chest, upper back, and shoulders for 28 days.", 
                "intervention_name": "Dapsone Formulation A", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Dapsone Formulation B", 
                "description": "Dapsone Formulation B applied once daily to the face, upper chest, upper back, and shoulders for 28 days.", 
                "intervention_name": "Dapsone Formulation B", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Dapsone Formulation C", 
                "description": "Dapsone Formulation C applied once daily to the face, upper chest, upper back, and shoulders for 28 days.", 
                "intervention_name": "Dapsone Formulation C", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Dapsone 5% Gel", 
                "description": "Dapsone 5% gel (ACZONE\u00ae) applied twice daily to the face, upper chest, upper back, and shoulders for 28 days.", 
                "intervention_name": "Dapsone 5% Gel", 
                "intervention_type": "Drug", 
                "other_name": "ACZONE\u00ae"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Dapsone"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "February 11, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "College Station", 
                    "country": "United States", 
                    "state": "Texas"
                }
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "4", 
        "overall_official": {
            "affiliation": "Allergan", 
            "last_name": "Medical Director", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Cmax is the maximum plasma level following multiple doses of dapsone. Plasma is the liquid component of the blood in which the blood cells are suspended.", 
            "measure": "Maximum Plasma Level (Cmax) of Dapsone", 
            "safety_issue": "No", 
            "time_frame": "Day 28"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01773122"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Cmax is the maximum plasma level following multiple doses of dapsone. Plasma is the liquid component of the blood in which the blood cells are suspended. The dapsone metabolites are N-acetyl dapsone and dapsone hydroxylamine.", 
            "measure": "Maximum Plasma Level (Cmax) of Dapsone Metabolites", 
            "safety_issue": "No", 
            "time_frame": "Day 28"
        }, 
        "source": "Allergan", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Allergan", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}